Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2009

Open Access 01-12-2009 | Research

The cost and impact of male circumcision on HIV/AIDS in Botswana

Authors: Lori A Bollinger, John Stover, Godfrey Musuka, Boga Fidzani, Themba Moeti, Lesego Busang

Published in: Journal of the International AIDS Society | Issue 1/2009

Login to get access

Abstract

The HIV/AIDS epidemic continues to be a major issue facing Botswana, with overall adult HIV prevalence estimated to be 25.7 percent in 2007. This paper estimates the cost and impact of the draft Ministry of Health male circumcision strategy using the UNAIDS/WHO Decision-Makers' Programme Planning Tool (DMPPT). Demographic data and HIV prevalence estimates from the recent National AIDS Coordinating Agency estimations are used as input to the DMPPT to estimate the impact of scaling-up male circumcision on the HIV/AIDS epidemic. These data are supplemented by programmatic information from the draft Botswana National Strategy for Safe Male Circumcision, including information on unit cost and program goals. Alternative scenarios were developed in consultation with stakeholders. Results suggest that scaling-up adult and neonatal circumcision to reach 80% coverage by 2012 would result in averting almost 70,000 new HIV infections through 2025, at a total net cost of US$47 million across that same period. This results in an average cost per HIV infection averted of US$689. Changing the target year to 2015 and the scale-up pattern to a linear pattern results in a more evenly-distributed number of MCs required, and averts approximately 60,000 new HIV infections through 2025. Other scenarios explored include the effect of risk compensation and the impact of increasing coverage of general prevention interventions. Scaling-up safe male circumcision has the potential to reduce the impact of HIV/AIDS in Botswana significantly; program design elements such as feasible patterns of scale-up and inclusion of counselling are important in evaluating the overall success of the program.
Literature
1.
go back to reference National AIDS Coordinating Agency: HIV/AIDS in Botswana: Estimated Trends and Implications Based on Surveillance and Modeling. Gaborone. 2008. National AIDS Coordinating Agency: HIV/AIDS in Botswana: Estimated Trends and Implications Based on Surveillance and Modeling. Gaborone. 2008.
2.
go back to reference Ministry of Health, Republic of Botswana: Botswana Safe Male Circumcision Add-on Strategy for HIV Prevention, DRAFT. Gaborone. 2008. Ministry of Health, Republic of Botswana: Botswana Safe Male Circumcision Add-on Strategy for HIV Prevention, DRAFT. Gaborone. 2008.
3.
go back to reference Auvert B, Taljaard D, Lagaarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005, 2 (11) : e298.CrossRefPubMed Auvert B, Taljaard D, Lagaarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005, 2 (11) : e298.CrossRefPubMed
4.
go back to reference Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized, controlled trial. Lancet 2007, 369 (9562) : 657–66.CrossRefPubMed Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized, controlled trial. Lancet 2007, 369 (9562) : 657–66.CrossRefPubMed
5.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized, controlled trial. Lancet 2007, 369 (9562) : 643–56.CrossRefPubMed Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized, controlled trial. Lancet 2007, 369 (9562) : 643–56.CrossRefPubMed
6.
go back to reference Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006, 3 (7) : e262.CrossRefPubMed Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006, 3 (7) : e262.CrossRefPubMed
7.
go back to reference Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007, 7: 16.CrossRefPubMed Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007, 7: 16.CrossRefPubMed
8.
go back to reference Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M: The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007, 21: 845–850.CrossRefPubMed Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M: The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007, 21: 845–850.CrossRefPubMed
9.
go back to reference Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006, 3: e517.CrossRefPubMed Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006, 3: e517.CrossRefPubMed
10.
go back to reference Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG: Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS ONE 2008, 3: e2679.CrossRefPubMed Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG: Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS ONE 2008, 3: e2679.CrossRefPubMed
11.
go back to reference Londish GJ, Murray JM: Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol 2008, 37: 1246–1253.CrossRefPubMed Londish GJ, Murray JM: Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol 2008, 37: 1246–1253.CrossRefPubMed
12.
go back to reference Podder CN, Sharomi O, Gumel AB, Moses S: To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol 2007, 69: 2447–2466.CrossRefPubMed Podder CN, Sharomi O, Gumel AB, Moses S: To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol 2007, 69: 2447–2466.CrossRefPubMed
13.
go back to reference Stover J, Fidzani B, Molomo BC, Moeti T, Musuka G: Estimated HIV trends and program effects in Botswana. PLoS ONE 2008, 3 (11) : e3729. doi:10.1371/journal.pone.0003729CrossRefPubMed Stover J, Fidzani B, Molomo BC, Moeti T, Musuka G: Estimated HIV trends and program effects in Botswana. PLoS ONE 2008, 3 (11) : e3729. doi:10.1371/journal.pone.0003729CrossRefPubMed
15.
go back to reference Brown T, Grassly NC, Garnett G, Stanecki K: Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. Sex Trans Inf Sex Transm Infect. 2006 Jun;82 Suppl 3:iii34–40. 2006, 82 (Suppl 3) : 34–40. Brown T, Grassly NC, Garnett G, Stanecki K: Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. Sex Trans Inf Sex Transm Infect. 2006 Jun;82 Suppl 3:iii34–40. 2006, 82 (Suppl 3) : 34–40.
16.
go back to reference Stover J: AIM: A Computer Program for Making HIV/AIDS Projections and Examining the Demographic and Social Impacts of AIDS. Washington, DC: USAID Health Policy Initiative; 2009. Stover J: AIM: A Computer Program for Making HIV/AIDS Projections and Examining the Demographic and Social Impacts of AIDS. Washington, DC: USAID Health Policy Initiative; 2009.
17.
go back to reference Martin G, Bollinger L, Pandit-Rajani T, Tshelo R, Nkambula R, Forsythe S, Stover J: Costing Male Circumcision in Lesotho, Swaziland and Zambia: Implications for the Cost-Effectiveness of Male Circumcision as a Cost-Effective Intervention for HIV Prevention. Washington DC; USAID Health Policy Initiative; 2007. Martin G, Bollinger L, Pandit-Rajani T, Tshelo R, Nkambula R, Forsythe S, Stover J: Costing Male Circumcision in Lesotho, Swaziland and Zambia: Implications for the Cost-Effectiveness of Male Circumcision as a Cost-Effective Intervention for HIV Prevention. Washington DC; USAID Health Policy Initiative; 2007.
18.
go back to reference ACHAP: Roadmap to Sustainability Report. Gaborone 2008. ACHAP: Roadmap to Sustainability Report. Gaborone 2008.
Metadata
Title
The cost and impact of male circumcision on HIV/AIDS in Botswana
Authors
Lori A Bollinger
John Stover
Godfrey Musuka
Boga Fidzani
Themba Moeti
Lesego Busang
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2009
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-12-7

Other articles of this Issue 1/2009

Journal of the International AIDS Society 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.